|
Resverlogix & EVERSANA Announce Partnership to Support the Pending Launch of the Initial Commercialization of Apabetalone for COVID-19 in US & Canada
|
1
|
Resverlogix Corp.
|
Jun 03, 2021 10:38AM
|
|
Resverlogix presented at Vascular Discovery 2018
|
8
|
Resverlogix Corp.
|
May 17, 2018 03:43PM
|
|
Repurposing Medications for Treatment of Pulmonary Arterial Hypertension: What’s Old Is New Again
|
3
|
Resverlogix Corp.
|
Feb 02, 2019 10:51AM
|
|
Reports of exempt distribution on SEDAR
|
4
|
Resverlogix Corp.
|
Mar 28, 2018 11:09PM
|
|
Reply from Sarah
|
3
|
Zenith Epigenetics
|
Dec 11, 2015 02:21PM
|
|
Renal trial delayed (again)
|
6
|
Resverlogix Corp.
|
Sep 27, 2017 10:19PM
|
|
Renal Phase 2a Trial Now Listed on ClinicalTrial.gov
|
5
|
Resverlogix Corp.
|
May 19, 2017 01:06PM
|
|
Renal and Fabry trial listings updated on ClinicalTrials.gov
|
5
|
Resverlogix Corp.
|
Apr 20, 2018 04:53PM
|
|
Remaining Q2 2016 Events (RVX and Zenith)
|
3
|
Resverlogix Corp.
|
May 05, 2016 11:32AM
|
|
Remaining Q2 2016 Events (RVX and Zenith)
|
1
|
Zenith Epigenetics
|
May 05, 2016 11:32AM
|
|
REDUCE-IT CVOT Meets Primary Endpoint
|
6
|
Resverlogix Corp.
|
Sep 24, 2018 10:01AM
|
|
Recent presentations
|
8
|
Resverlogix Corp.
|
Dec 13, 2021 11:00AM
|
|
Recent changes
|
2
|
BIOASIS TECHNOLOGIES INC
|
Mar 31, 2019 08:19AM
|
|
Reata, Bardoxolone, NRF2, CKD, Mitochondria, Inflammation, Redox Balance, Reactive Oxygen Species
|
7
|
Resverlogix Corp.
|
Jun 14, 2019 08:01AM
|
|
Reata, Bardoxolone and NRF2
|
2
|
Resverlogix Corp.
|
Jun 05, 2019 12:19PM
|
|
Re: … Zack’s analyst report's impact...
|
4
|
Resverlogix Corp.
|
Nov 04, 2015 01:05PM
|
|
Re: … Zack’s analyst report's impact...
|
1
|
Resverlogix Corp.
|
Nov 04, 2015 03:28PM
|
|
Re: … well, where are we at...?..
|
3
|
Resverlogix Corp.
|
Jun 10, 2015 02:21PM
|
|
Re: “We will see how close we got”.....
|
4
|
Resverlogix Corp.
|
Nov 17, 2019 08:14AM
|
|
Re: “We will see how close we got”.....
|
8
|
Resverlogix Corp.
|
Nov 17, 2019 08:57AM
|
